Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 12
Abstract
[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness. [Methods] A total of 5 827 patients who received platelet transfusion in the PLA General Hospital from May 2023 to May 2024 were selected as the research subjects, among which 4 780 patients were transfused with 1 therapeutic dose of platelets, and 1 047 patients were transfused with 0.5 therapeutic dose of platelets, and the efficacy of platelet transfusion was compared between the two groups. The effects of gender, disease type, white blood cell count before transfusion, fever, number of platelet transfusions, and platelet antibodies on platelet transfusion refractoriness were analyzed using univariate analysis, and the independent risk factors affecting platelet transfusion refractoriness were further analyzed by multivariate logistic regression. [Results] Among 4 780 patients, 3553 (74.3%) were effective and 1 227 (25.7%) were ineffective. Among 1 047 patients, 0.5 platelet infusion was effective in 755 cases (72.1%) and ineffective in 292 cases (27.9%). There was no significant difference in the effective rate of platelet transfusion between the two groups (P>0.05). Univariate analysis showed that the therapeutic effect of platelet transfusion was related to age, the number of platelet transfusion, disease type, platelet antibodies and white blood cell count before transfusion (P<0.05), while age, gender, fever and blood type were not related to the therapeutic effect of platelet transfusion (P>0.05). The results of multi-factor analysis showed that age, white blood cell count >50×109/L, platelet transfusion times, disease type and platelet antibody were independent risk factors for ineffective transfusion (P<0.05). [Conclusion] There is no significant difference in the efficacy of platelet infusion with 0.5 therapeutic dose or 1 therapeutic dose. In addition, age, white blood cell count >50×109/L, the number of platelet transfusion, disease type and platelet antibodies were the factors affecting the ineffective platelet transfusion in group 2.
Authors and Affiliations
Jianling ZHU, Tingting CHENG, Chunya MA, Lihui FU, Hongmei SHI, Yang YU
Keywords
Related Articles
- EP ID EP754454
- DOI 10.13303/j.cjbt.issn.1004-549x.2024.12.007
- Views 6
- Downloads 0
Identification and test methods of rare unexpected antibodies in grassroots medical institutions
Objective To explore how to identify rare unexpected antibodies using routine serology methods in blood transfusion department of grassroots hospitals. Methods A patient with gastrointestinal bleeding with inconsistent f...
Following up and re-entry of HBV reactive blood donors in Yantai area
Objective To analyze the preliminary screening and follow-up testing data of HBV in Yantai area, and discuss the rationality of following up and re-entry program of HBV reactive blood donors. Methods Donors who were sing...
Hepatitis E virus prevalence among blood donors in Wuhan
Objective To investigate the prevalence and risk factor of hepatitis E virus(HEV) infection among blood donors in Wuhan. Methods A total of 1 302 serum samples (including 1 076 with normal ALT and 226 with elevated ALT)...
Research progress on iron nutritional status of plateletpheresis donors
Apheresis platelets are extensively utilized in clinical practice due to high purity and minimal side effects. These platelets are primarily obtained from regular blood donors. However, there is no consensus on whether p...
Application and prospects of homologous allogeneic platelet-rich plasma in wound repair
The application of platelet-rich plasma (PRP) in wound repair is progressively garnering attention. However, certain patients, owing to relative or absolute contraindications, encounter impediments in the acquisition or...